Skip to content

Effect of Mustadi Yapana Basti Punarnavadi Ghanavati Veerataradi Ghanavati Trikantakadi Ghanavati in Chronic Kidney Disease

Three Arm Randomized Comparative Clinical Study To Evaluate the Combined Effect of Mustadi Yapana Basti Followed by Punarnavadi Ghanavati Veerataradi Ghanavati And Trikantakadi Ghanavati in Chronic Kidney Disease

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/050137
Enrollment
120
Registered
2023-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N182- Chronic kidney disease, stage 2 (mild) Health Condition 2: N189- Chronic kidney disease, unspecified

Interventions

None listed

Sponsors

Dr Ashwini Sajjanavar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of Chronic Kidney Disease Patients. • Subjects who are fit for Bastikarma. • Subjects having classical common signs and symptoms Gaurava,Anavasthita utseda,Siratanutwa,Salomaharsha,Angavivarnata,Sashoolamutrata,Raktamootrata. • Subjects with classical symptoms of Chronic Kidney Disease having clinical features like oedema,pruritis, generalized weakness, nausea. • Stages 1, 2 and 3 Glomerular Filtration Rate (30-ml/min per 1.73m2 ) • Microalbuminuria( ACR- 30 to 300mg/g >=3 months) • Mild hypertension( • Patients aged between 20-70years. • Patients of either sex will be taken for study.

Exclusion criteria

Exclusion criteria: Patients of Congenital Renal Diseases like Autosomal dominant and Recessive Polycystic Kidney disease, Congenital Nephrotic syndrome (Finnish type), Alportâ??s syndrome, Fabryâ??s disease and Juvenile Nephronopthisis. • Subjects who are on dialysis. • Uncontrolled Dm.(HBA1C >=7) • Pregnant women.

Design outcomes

Primary

MeasureTime frame
ALPAMUTRATA PADASHOTHATimepoint: 30days

Secondary

MeasureTime frame
SERUM CREATININE GFR LEVELSTimepoint: 30DAYS

Countries

India

Contacts

Public ContactDr Ashwini Sajjanavar

AYURVEDA MAHAVIDYALAYA HUBLI

drprashanthas@gmail.com9448135575

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026